| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| FMOC-(4S,2RS)-2-甲基噻唑烷-4-羧酸 | PKTPKKAKKL | 164669-07-2 | C53H99N15O12 |
| FMOC-(4-氨甲基)苯甲酸 | N-(9-fluorenylmethyloxycarbonyl)-4-(aminomethyl)benzoic acid | 164470-64-8 | C23H19NO4 |
| FMOC-(3S,4S)-4-氨基-3-羟基-5-苯基戊酸 | Fmoc-(3 S,4 S)-4-amino-3-hydroxy-5-phenylpentanoic acid | 198542-01-7 | C26H25NO5 |
| FMOC-(2S,6S,9S)-6-氨基-2-羧甲基-3,8-二氮杂双环(4,3,0)壬烷-1,4-二酮 | [(3S,7S,8aS)-7-(9H-Fluoren-9-ylmethoxycarbonylamino)-1,4-dioxo-octahydro-pyrrolo[1,2-a]pyrazin-3-yl]-acetic acid | 184700-26-3 | C24H23N3O6 |
| FMOC-(2R,4S)-4-羟基吡咯烷-2-羧酸 | N-Fmoc 4-hydroxypropline | 139262-20-7 | C20H19NO5 |
| FK506束缚蛋白质-25 | 4-Amino-N-(hexahydro-1-methyl-2H-azepin-2-ylidene)benzenesulfonamide | 126826-62-8 | C13H19N3O2S |
| FK-506一水合物 | Tacrolimus monohydrate | 109581-93-3 | C44H71NO13 |
| FIBRINOGEN-BINDING肽 | Glutamyl-histidyl-isoleucyl-prolyl-alanine | 137235-80-4 | C25H39N7O8 |
| FGFR1酪氨酸激酶抑制剂(PD-166866) | PD 166866 | 192705-79-6 | C20H24N6O3 |
| FG-4592中间体7 | methyl 1-((dimethylamino)methyl)-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | 1509958-19-3 | C20H20N2O4 |
| FERROVANADIUM合金) | vanadium iron powder | 11147-86-7 | FeV |
| FCLA自由酸[化学发光试剂] | 2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-5-[({2-[4-(2-methyl-3-oxo-3,7-dihydroimidazo[1,2-a]pyrazin-6-yl)phenoxy]ethyl}carbamothioyl)amino]benzoic acid | 133118-06-6 | C36H27N5O7S |
| FAS活化的丝/苏氨酸激酶抗体 | Fas-activated serine/threonine kinase | 170347-50-9 | —— |
| FAM叠氮化物,6-异构体 | N-(3-azidoprop-1-yl)fluoresceinyl-6-carboxamide | 1386385-76-7 | C24H18N4O6 |
| F1-20蛋白质 | 3-Ethyl-2-methylquinoxalin-5-amine | 126987-75-5 | C11H13N3 |
| Emixustat盐酸盐 | emixustat hydrochloride | 1141934-97-5 | C16H25NO2*ClH |
| Elacestrant 二盐酸盐 | Elacestrant hydrochloride | 1349723-93-8 | C30H40Cl2N2O2 |
| EZH2甲基转移酶抑制剂(GSK126) | GSK-126 | 1346574-57-9 | C31H38N6O2 |
| EZATIOSTAT游离的 | γ-glutamyl-S-(benzyl)cysteinyl-(R)-(-)-phenylglycine diethyl ester | 168682-53-9 | C27H35N3O6S |
| EVACETRAPIB中间体 | methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetra-hydro-1H-benzo[b]azepine-1-carboxylate | 1259393-27-5 | C14H17NO3 |
| ETHYLONE盐酸盐 | bk-MDEA (hydrochloride) | 1454266-19-3 | C12H16ClNO3 |
| ERK抑制剂II,阴性对照 | ERK Inhibitor II, Negative Control | 1177970-73-8 | C18H12N6O |
| EP杂质R2,3-二氢三尖杉宁碱 | N-debenzoyl-N-((S)-2-methylbutanoyl)paclitaxel | 158948-96-0 | C45H55NO14 |
| EPZ005687抑制剂 | EPZ005687 | 1396772-26-1 | C32H37N5O3 |
| EPSILON-(GAMMA-L-谷氨酰)-L-赖氨酸 | epsilon-(gamma-glutamyl)lysine | 17105-15-6 | C11H21N3O5 |
| ENS-163磷酸盐 | ENS-163 phosphate | 117707-51-4 | C11H19N2O5PS |
| EMT抑制剂-1 | 4-((4-(3,4-dichlorophenyl)-1,2,5-thiadiazol-3-yl)oxy)butan-1-ol | 1638526-21-2 | C12H12Cl2N2O2S |
| EMD638683 (形态 S); (alphaS)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 | N'-[(S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide | 1184940-46-2 | C18H18F2N2O4 |
| EMD638683 (形态 R); (alphaR)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 | N'-[(R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide | 1184940-47-3 | C18H18F2N2O4 |
| EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 | tepotinib | 1100598-32-0 | C29H28N6O2 |
| ELA锁链素 | 4-(16-(S)-amino-16-carboxybutyl)-1-(11-(S)-amino-11-carboxypentyl)-3,5-bis-(20,20’-(S)-amino-20,20’-carboxypropyl)pyridinium | 11003-57-9 | C24H40N5O8 |
| EIPA盐酸盐 | ethylisopropyl amiloride hydrochloride | 1345839-28-2 | C11H18ClN7O*ClH |
| EGFR-IN-9(化合物8) | N-{3-[4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]-pyrimidin-5-yl]phenyl}acrylamide | 1226549-39-8 | C29H24N4O3 |
| EED抑制剂(EEDINHIBITOR-1) | MAK683 | 1951408-58-4 | C20H17FN6O |
| EDTA钙盐 | Ethylenediaminetetraacetic acid dicalcium salt | 19709-85-4 | C10H12Ca2N2O8 |
| EA671;;二噻吩[3,2-E:2,3-G]-2,1,3-苯并噻二唑 | dithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole | 1256138-50-7 | C10H4N2S3 |
| E3330抑制剂 | E 3330 | 136164-66-4 | C21H30O6 |
| E-阿魏酸二十二烷基酯 | Docosylferulate | 101927-24-6 | C32H54O4 |
| E-甲基-3-(5-甲酰基-2-呋喃基)-(2-对甲氧基苯基)丙烯酸酯 | E-methyl-3-(5-formyl-2-furyl)-(2-p-methoxyphenyl) acrylate | 105199-78-8 | C16H14O5 |
| E-甲基-3-(2-呋喃基)-(2-甲基苯基)丙烯酸酯 | E-methyl-3-(2-furyl)-(2-m-methylphenyl) acrylate | 105199-76-6 | C15H14O3 |
| E-甲基-3-(2-呋喃基)-(2-对甲氧基苯基)丙烯酸酯 | E-methyl-3-(2-furyl)-(2-p-methoxyphenyl) acrylate | 105199-75-5 | C15H14O4 |
| E-咖啡酸戊酯 | Caffeic Acid n-Pentyl Ester | 136944-11-1 | C14H18O4 |
| E-三丁基-1-苯基-丙烯基锡烷 | E-tributyl-1-phenyl-propenylstannane | 125405-88-1 | C21H36Sn |
| E-三丁基-1-苯基-丙烯基锡烷 | 1-(tributylstannyl)-1-phenyl-1-propene | 112713-91-4 | C21H36Sn |
| E-9-(β-硝基乙烯基)久洛尼定 | 9-(2-nitro-vinyl)-2,3,6,7-tetrahydro-1<i>H</i>,5<i>H</i>-pyrido[3,2,1-<i>ij</i>]quinoline | 101077-26-3 | C14H16N2O2 |
| E-7-(2-溴苯基)庚-4-烯酸乙酯 | E-7-(2-bromophenyl)hept-4-enoic acid ethyl ester | 188004-31-1 | C15H19BrO2 |
| E-4-氰基-3-戊基-3-丁烯酸甲酯 | E-4-cyano-3-pentyl-3-butenoic acid methyl ester | 102928-78-9 | C11H17NO2 |
| E-4-氯-4-戊基-3-丁烯酸甲酯 | E-4-chloro-4-pentyl-3-butenoic acid methyl ester | 102928-80-3 | C10H17ClO2 |
| E-4-(4-氟苯基)-3-丁烯酸 | (E)-4-(4-fluorophenyl)but-3-enoic acid | 127404-66-4 | C10H9FO2 |
| E-2-甲氧基-1-丙酮苯腙 | E-2-methoxy-1-propanone phenylhydrazone | 116171-47-2 | C10H14N2O |